does glp 1 cause kidney issues GLP-1 agonists in the treatment of chronic disease in type 2 diabetes and obesity Potential kidney-protective and other effects

The implications are different by segment

These sugar consumption-associated alterations could contribute to pathological overeating [145]

Future studies will be crucial in addressing existing challenges, optimizing dosing regimens, and expanding their applications to maximize their impact on patient care

GLP-1 agonist oral formulations are significantly less expensive than injectable forms

doi: 10.1007/s13300-023-01516-z

Since natural GLP-1 is rapidly deactivated by an enzyme in our blood, by the time GLP-1 is secreted by our gut, makes it through our liver, heart, and lungs, then out into our arteries, only to later reach the veins where the lab tech is pulling out blood, the levels we see are lower than the arterial levels that GLP-1 receptors are exposed to throughout our body, though only by a relatively small amount